Metabolik sendromun tedavisi
Yükleniyor...
Dosyalar
Tarih
2013
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Bugünlerde, metabolik sendrom bütün dünyada büyük bir sağlık problem oluşturmaktadır. Metabolik sendrom, yüksek kan basıncı, obezite, insülin rezistansı ve diabetes mellitus ile karakterizedir. Metabolik sendromlu hastalar yaşam şekillerini değiştirmelidir. Metabolik sendromlu hastaların tedavisinde fiziksel aktivite, diyetteki değişiklikler ve kilo kaybı gereklidir. Bu hastalar, yaşam şekli değişikliği ile tedaviyi başaramazsa, bazı ilaçlar kullanmalıdırlar. İlk olarak, insülin rezistansının tedavi edilmesi gerekir. İnsülin rezistansının ve diabetes mellitusun tedavisinde metformin, tiazolidinedionlar veya glitazonlar kullanılmalıdır. İkinci olarak, dislipidemi ve obezitenin statin ve fibratlarla tedavi edilmesi gerekir. Kardiyovasküler hastalıklar, hipertansiyon ve polikistik over sendromu gibi metabolik sendromun birleşenlerinin tedavisi genellikle insülin rezistansının, obezitenin ve dislipideminin tedavisi ile ilişkilidir. Çünkü, insülin rezistansı metabolik sendromun temel sebebini oluşturmaktadır. Metabolik sendrom erken tedavi edilmelidir, çünkü geciken tedaviler yetersiz kalmakta ve çok pahalı olmaktadır. Bu derlemenin amacı, metabolik sendrom, korunması ve tedavisini güncel bilgiler ışığında yansıtmaktır.
Nowadays, metabolic syndrome is becoming big public health problem in the world. It is characteristic with high blood pressure, obesity, insulin resistance and diabetes mellitus. Patients with metabolic syndrome should change their lifestyle. Physical activities, changing diet and weight loss are essential in the treatment. When patients with metabolic syndrome do not achieve their treatment, they should use some drugs. Firstly, treatment of insulin resistance is essential. Metformin, thiazolidinedions or glitazons should be used in the treatment of insulin resistance and diabetes mellitus. Secondly, dyslipidemia and obesity should be treated with statin and fibrat. Metabolic syndrome’s other components like cardiovascular disease, hypertension and polycystic ovary syndrome’s treatment is generally linked with the treatment of insulin resistance, obesity and dyslipidemia since the insulin resistance is the main factor in the metabolic syndrome. Metabolic syndrome should be early treated, because later treatments are inadequate and very expensive. The aim of this review is to reflect the metabolic syndrome, its prevention and treatment in the light of current knowledge availabl
Nowadays, metabolic syndrome is becoming big public health problem in the world. It is characteristic with high blood pressure, obesity, insulin resistance and diabetes mellitus. Patients with metabolic syndrome should change their lifestyle. Physical activities, changing diet and weight loss are essential in the treatment. When patients with metabolic syndrome do not achieve their treatment, they should use some drugs. Firstly, treatment of insulin resistance is essential. Metformin, thiazolidinedions or glitazons should be used in the treatment of insulin resistance and diabetes mellitus. Secondly, dyslipidemia and obesity should be treated with statin and fibrat. Metabolic syndrome’s other components like cardiovascular disease, hypertension and polycystic ovary syndrome’s treatment is generally linked with the treatment of insulin resistance, obesity and dyslipidemia since the insulin resistance is the main factor in the metabolic syndrome. Metabolic syndrome should be early treated, because later treatments are inadequate and very expensive. The aim of this review is to reflect the metabolic syndrome, its prevention and treatment in the light of current knowledge availabl
Açıklama
Anahtar Kelimeler
Diabetes mellitus, Metabolik sendrom, Obezite, Diabetes Mellitus, Metabolic syndrome, Obesity
Kaynak
Atatürk Üniversitesi Veteriner Bilimleri Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
8
Sayı
3
Künye
Dik, B. (2013). Metabolik Sendromun Tedavisi. Atatürk Üniversitesi Veteriner Bilimleri Dergisi, 8(3), 259-269.
